Jefferies Upgrades AstraZeneca (AZN) to Buy
Jefferies analyst Peter Welford upgraded AstraZeneca (NASDAQ: AZN) from Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
